NUCLEOTIDE BASED MEDICAMENT AND METHOD OF USE FOR TREATMENT OF CONDITIONS IN HUMANS

Details for Australian Patent Application No. 2003295777 (hide)

Owner DSS GLOBAL, INC.

Inventors Dentone, Alfred J.; Koppel, Peter; Whitehead, John; Schel, Charles L.

Agent Halfords IP of **** Street Sydney NSW 2000 Australia

Pub. Number AU-A-2003295777

PCT Number PCT/US2003/0372

PCT Pub. Number WO2004/047737

Priority 60/441,205 17.01.03 US; 60/428,321 21.11.02 US

Filing date 21 November 2003

Wipo publication date 18 June 2004

Event Publications

22 April 2004 Complete Application Filed

  Priority application(s): 60/441,205 17.01.03 US; 60/428,321 21.11.02 US

22 July 2004 Application Open to Public Inspection

  Published as AU-A-2003295777

17 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003295778-FUEL CELL SYSTEM WITH IMPROVED HUMIDIFICATION SYSTEM

2003295776-2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer